Today: 5 March 2026

Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

Amphenol Corporation stock jumps 8% as CEO set to become chairman; dividend date looms

Amphenol Corporation stock jumps 8% as CEO set to become chairman; dividend date looms

Amphenol shares surged nearly 8% to $137.90 midday Friday, outpacing the S&P 500 and Nasdaq 100 gains. The move follows a sharp drop Thursday and comes as CEO R. Adam Norwitt is set to become chairman, with Martin H. Loeffler retiring. Vice president Michael Ivas exercised and gifted 25,000 shares each on Feb. 4. Amphenol will pay a $0.25 dividend April 14 to holders as of March 23.
6 February 2026
Exxon Mobil stock price jumps as XOM shrugs off softer oil — what traders watch next

Exxon Mobil stock price jumps as XOM shrugs off softer oil — what traders watch next

Exxon Mobil shares rose 2.1% to $149.12 by midday Friday, nearing the week’s high after a 1% drop Thursday. The stock moved between $146.00 and $149.55 during the session as oil prices slid amid U.S.-Iran talks and sector analysts split on Exxon’s outlook. Brent crude fell to $67 a barrel, while U.S. WTI eased to $62.69. Exxon maintained its $20 billion buyback plan despite volatility.
6 February 2026
Uber stock slides as jury verdict adds legal risk, even with fresh robotaxi push

Uber stock slides as jury verdict adds legal risk, even with fresh robotaxi push

A U.S. jury ordered Uber to pay $8.5 million in the first of over 3,000 lawsuits alleging sexual assault by drivers. Uber shares fell 1.5% to $74.08 by midday Friday. The company and WeRide announced plans to deploy at least 1,200 robotaxis in Abu Dhabi, Dubai, and Riyadh, pending regulatory approval. CFO Prashanth Mahendra‑Rajah will depart on Feb. 16.
Coherent stock jumps on AI optics demand bets as Wall Street lifts price targets

Coherent stock jumps on AI optics demand bets as Wall Street lifts price targets

Coherent shares rose 7.3% to $224.59 Friday after the company issued strong Q3 guidance and analysts raised price targets. Fiscal Q2 revenue reached $1.69 billion with adjusted EPS of $1.29. The company expects Q3 revenue between $1.70 billion and $1.84 billion, and EPS of $1.28 to $1.48. Demand from datacenter optics led growth, while industrial sales remained weaker.
Applied Materials stock jumps nearly 6% as Citi lifts target to $400, eyes turn to Feb. 12 earnings

Applied Materials stock jumps nearly 6% as Citi lifts target to $400, eyes turn to Feb. 12 earnings

Applied Materials shares rose 5.7% to $321.20 by midday after Citi raised its price target to $400 and kept a Buy rating ahead of the Feb. 12 earnings report. Traders are focused on guidance for chip-factory investment and demand from China. Peers Lam Research and KLA also posted strong gains.
GE Vernova stock jumps 4% as Baird turns bullish and $2.6 billion bond deal settles

GE Vernova stock jumps 4% as Baird turns bullish and $2.6 billion bond deal settles

GE Vernova shares rose about 4% to $767.26 by midday Friday after Baird upgraded the stock to Outperform and raised its price target to $923. The company completed a $2.6 billion senior notes offering to help fund its acquisition of the remaining Prolec GE stake. The rebound follows a two-day slide that erased a recent winning streak. First-quarter earnings are scheduled for April 22.
6 February 2026
Costco stock price today: COST hovers near $1,000 after January sales pop and fresh Wall Street calls

Costco stock price today: COST hovers near $1,000 after January sales pop and fresh Wall Street calls

Costco shares rose 0.6% Friday to about $995 after reporting January net sales of $21.33 billion, up 9.3% year-over-year. Oppenheimer and Baird raised their price targets to $1,100, citing strong sales momentum, while Roth MKM maintained a sell rating at $769. Comparable sales climbed 7.1%, with digital sales up 34.4%. The company cited calendar effects as a drag on January results.
6 February 2026
IREN stock price whipsaws after Q2 miss as Microsoft GPU financing takes center stage

IREN stock price whipsaws after Q2 miss as Microsoft GPU financing takes center stage

IREN shares surged nearly 7% to $42.64 Friday after plunging 11% on a quarterly revenue miss. The bitcoin miner reported a $155.4 million net loss and $184.7 million revenue for the quarter, down from the previous period. IREN announced $3.6 billion in GPU financing tied to a Microsoft deal and plans for a new Oklahoma data center. Most revenue remains linked to crypto, despite the AI cloud pivot.
UnitedHealth (UNH) stock rebounds nearly 2% as sector digests cost shock, Mizuho trims target

UnitedHealth (UNH) stock rebounds nearly 2% as sector digests cost shock, Mizuho trims target

UnitedHealth shares rose 1.9% to $273.79 Friday, rebounding after Molina Healthcare’s weak 2026 profit outlook sent sector stocks tumbling Thursday. Mizuho cut its price target for UnitedHealth to $350 but kept an Outperform rating. Investors await the April 6 CMS decision on 2027 Medicare Advantage rates. Molina shares plunged nearly 28%, while Centene fell 5.5% and Cigna gained about 3%.
6 February 2026
ServiceNow stock price slips as Wall Street sorts AI winners from losers

ServiceNow stock price slips as Wall Street sorts AI winners from losers

ServiceNow shares fell 1.3% to $101.25 in late-morning trading Friday, capping a roughly 12% drop for the week. The iShares Expanded Tech-Software ETF slid about 19% over eight sessions, its sharpest decline in nearly six years. Investors shifted away from software stocks amid doubts over AI infrastructure spending. ServiceNow’s annual report was filed Jan. 29; its CEO received 40,014 restricted stock units set to vest Feb. 7.
Boston Scientific stock price steadies after historic plunge as investors zero in on heart-rhythm outlook

Boston Scientific stock price steadies after historic plunge as investors zero in on heart-rhythm outlook

Boston Scientific shares slipped 0.2% to $77.49 in late-morning trading Friday, lagging a broader market rally. The stock remains under pressure after its electrophysiology segment missed sales estimates in the fourth quarter, triggering its steepest drop in over 25 years. Investors are watching for signs management can meet first-quarter growth targets. Trading volume stayed elevated as analysts revised forecasts.
6 February 2026
1 88 89 90 91 92 687
Go toTop